0001209191-19-028040.txt : 20190507
0001209191-19-028040.hdr.sgml : 20190507
20190507175127
ACCESSION NUMBER: 0001209191-19-028040
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190501
FILED AS OF DATE: 20190507
DATE AS OF CHANGE: 20190507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEBEL MARLENE
CENTRAL INDEX KEY: 0001770295
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15787
FILM NUMBER: 19804407
MAIL ADDRESS:
STREET 1: METLIFE, INC.
STREET 2: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: METLIFE INC
CENTRAL INDEX KEY: 0001099219
STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311]
IRS NUMBER: 134075851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
BUSINESS PHONE: 212-578-5500
MAIL ADDRESS:
STREET 1: 200 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10166
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-05-01
0
0001099219
METLIFE INC
MET
0001770295
DEBEL MARLENE
METLIFE, INC.
200 PARK AVENUE
NEW YORK
NY
10166
0
1
0
0
EVP & Chief Risk Officer
Common Stock
30085
D
Restricted Stock Units
Common Stock
7565
D
Employee Stock Options (right to buy)
31.15
2023-02-25
Common Stock
5513
D
Employee Stock Options (right to buy)
45.15
2024-02-24
Common Stock
10911
D
Employee Stock Options (right to buy)
45.91
2025-02-23
Common Stock
9703
D
Employee Stock Options (right to buy)
34.33
2026-02-22
Common Stock
13107
D
Employee Stock Options (right to buy)
46.85
2027-02-27
Common Stock
10600
D
Employee Stock Options (right to buy)
45.50
2028-03-01
Common Stock
10712
D
Employee Stock Options (right to buy)
44.65
2029-02-25
Common Stock
12013
D
Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. 1,179 shares were granted on February 28, 2017, 2,382 shares were granted on March 2, 2018, 4,004 shares were granted on February 26, 2019.
The reported number of underlying shares represent outstanding unexercised options that became (or will become) exercisable in three installments on each of the first three anniversaries of the Grant Date. The expiration date is the day before the tenth anniversary of the Grant Date.
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Mark A. Schuman, authorized signer
2019-05-07
EX-24.3_851120
2
poa.txt
POA DOCUMENT
EXHIBIT 24
LIMITED POWER OF ATTORNEY
FOR SECTION 16 REPORTING OBLIGATIONS
TO WHOM IT MAY CONCERN:
Pursuant to the authorization set forth in the instructions for the filing of
Form 3, Form 4, and Form 5, respectively (hereinafter referred to as the
"Reports"), under the requirements of the Securities Exchange Act of 1934, as
amended, the undersigned hereby designates and authorizes each of STEPHEN W.
GAUSTER, JEANNETTE N. PINA and MARK A. SCHUMAN to execute and file, or cause to
be filed, such Reports, and any amendments thereto, on behalf of the
undersigned, with the Securities and Exchange Commission and any other proper
bodies at any time when the filing of said Reports is in order, containing such
information as STEPHEN W. GAUSTER, JEANNETTE N. PINA, and MARK A. SCHUMAN may
deem advisable.
The authority of STEPHEN W. GAUSTER, JEANNETTE N. PINA, and MARK A. SCHUMAN
under this authorization shall continue until the undersigned is no longer
required to file Reports with regard to the undersigned's ownership of or
transactions in securities of MetLife, Inc., unless earlier revoked by the
undersigned in writing.
The undersigned acknowledges that STEPHEN W. GAUSTER, JEANNETTE N. PINA , and
MARK A. SCHUMAN are not assuming any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.
Signature: /s/ Marlene Debel
Name: MARLENE DEBEL
Date: 3/8/19